I didn't realise that peramavir wan't effective against the mutation. I've seen IV relenza mentioned a long time back.
Do you think GSK may take up the ROW rights to LANI? They seem to be promoting Relenza and their vaccines much more so in recent years and they compliment each other.
- Forums
- ASX - By Stock
- glaxosmithkline update: influenza a (h1n1)
I didn't realise that peramavir wan't effective against the...
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online